Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Trajectories of cognitive function prior to cancer diagnosis: a population-based study.

van der Willik KD, Hauptmann M, Jóźwiak K, Vinke EJ, Ruiter R, Stricker BH, Compter A, Ikram MA, Schagen SB.

J Natl Cancer Inst. 2019 Sep 9. pii: djz178. doi: 10.1093/jnci/djz178. [Epub ahead of print]

PMID:
31498410
2.

Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapy.

Malek R, Maj M, Wnorowski A, Jóźwiak K, Martin H, Iriepa I, Moraleda I, Chabchoub F, Marco-Contelles J, Ismaili L.

Bioorg Chem. 2019 Oct;91:103205. doi: 10.1016/j.bioorg.2019.103205. Epub 2019 Aug 16.

PMID:
31446330
3.

Imaging depth variations in hyperspectral imaging: Development of a method to detect tumor up to the required tumor-free margin width.

Kho E, de Boer LL, Post AL, Van de Vijver KK, Jóźwiak K, Sterenborg HJCM, Ruers TJM.

J Biophotonics. 2019 Jul 9:e201900086. doi: 10.1002/jbio.201900086. [Epub ahead of print]

PMID:
31290280
4.

Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms.

van Eden WJ, Kok NFM, Snaebjornsson P, Jóźwiak K, Woensdregt K, Bottenberg PD, Boot H, Aalbers AGJ.

BJS Open. 2019 Feb 19;3(3):376-386. doi: 10.1002/bjs5.50134. eCollection 2019 Jun.

5.

Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidence.

Min LA, Vogel WV, Lahaye MJ, Maas M, Donswijk ML, Vegt E, Kusters M, Zijlmans HJ, Jóźwiak K, Roberti S, Beets-Tan RGH, Lambregts DMJ.

Eur Radiol. 2019 May 22. doi: 10.1007/s00330-019-06253-1. [Epub ahead of print]

PMID:
31119418
6.

EZH2 Is Overexpressed in BRCA1-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based Chemotherapy.

Puppe J, Opdam M, Schouten PC, Jóźwiak K, Lips E, Severson T, van de Ven M, Brambillasca C, Bouwman P, van Tellingen O, Bernards R, Wesseling J, Eichler C, Thangarajah F, Malter W, Pandey GK, Ozretić L, Caldas C, van Lohuizen M, Hauptmann M, Rhiem K, Hahnen E, Reinhardt HC, Büttner R, Mallmann P, Schömig-Markiefka B, Schmutzler R, Linn S, Jonkers J.

Clin Cancer Res. 2019 Jul 15;25(14):4351-4362. doi: 10.1158/1078-0432.CCR-18-4024. Epub 2019 Apr 29.

PMID:
31036541
7.

Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.

Elbers JBW, Veldhuis LI, Bhairosing PA, Smeele LE, Jóźwiak K, van den Brekel MWM, Verheij M, Al-Mamgani A, Zuur CL.

Eur Arch Otorhinolaryngol. 2019 Mar;276(3):647-655. doi: 10.1007/s00405-019-05292-0. Epub 2019 Jan 23.

PMID:
30673847
8.

3-Furan-2-yl-N-p-tolyl-acrylamide, a highly selective positive allosteric modulator of α7 nicotinic receptors, produces anxiolytic-like activity in mice.

Targowska-Duda KM, Budzynska B, Michalak A, Jozwiak K, Biala G, Arias HR.

J Psychopharmacol. 2019 May;33(5):558-567. doi: 10.1177/0269881118821100. Epub 2019 Jan 15.

PMID:
30644335
9.

Cardiovascular Disease Risk After Treatment-Induced Premature Ovarian Insufficiency in Female Survivors of Hodgkin Lymphoma.

Krul IM, Opstal-van Winden AWJ, Janus CPM, Daniëls LA, Appelman Y, Maas AHEM, de Vries S, Jóźwiak K, Aleman BMP, van Leeuwen FE.

J Am Coll Cardiol. 2018 Dec 25;72(25):3374-3375. doi: 10.1016/j.jacc.2018.10.030. No abstract available.

PMID:
30573037
10.

Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.

Elbers JBW, Al-Mamgani A, van den Brekel MWM, Jóźwiak K, de Boer JP, Lohuis PJFM, Willems SM, Verheij M, Zuur CL.

Otolaryngol Head Neck Surg. 2019 Jun;160(6):1023-1033. doi: 10.1177/0194599818818443. Epub 2018 Dec 11.

PMID:
30526317
11.

Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma.

Kuusk T, De Bruijn R, Brouwer OR, De Jong J, Donswijk M, Hendricksen K, Horenblas S, Jóźwiak K, Prevoo W, Valdés Olmos RA, Van Der Poel HG, Van Rhijn BW, Wit EM, Bex A.

Scand J Urol. 2018 Oct - Dec;52(5-6):411-418. doi: 10.1080/21681805.2018.1531057. Epub 2018 Dec 11.

PMID:
30526184
12.

Structurally Simple, Readily Available Peptidomimetic 1-Benzyl-5-methyl-4-( n-octylamino)pyrimidin-2(1 H)-one Exhibited Efficient Cardioprotection in a Myocardial Ischemia (MI) Mouse Model.

Trifonov L, Nudelman V, Zhenin M, Matsree E, Afri M, Schmerling B, Cohen G, Jozwiak K, Weitman M, Korshin E, Senderowitz H, Shainberg A, Hochhauser E, Gruzman A.

J Med Chem. 2018 Dec 27;61(24):11309-11326. doi: 10.1021/acs.jmedchem.8b01471. Epub 2018 Dec 11.

PMID:
30507195
13.

An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors.

Kuusk T, Donswijk ML, Valdés Olmos RA, De Bruijn RE, Brouwer OR, Hendricksen K, Horenblas S, Jóźwiak K, Prevoo W, Van Der Poel HG, Van Rhijn BWG, Wit EM, Bex A.

EJNMMI Res. 2018 Dec 3;8(1):105. doi: 10.1186/s13550-018-0460-y.

14.

The presence and distribution of G protein-coupled receptor 35 (GPR35) in the human cornea - Evidences from in silico gene expression analysis and immunodetection.

Matysik-Woźniak A, Wnorowski A, Turski WA, Jóźwiak K, Jünemann A, Rejdak R.

Exp Eye Res. 2019 Feb;179:188-192. doi: 10.1016/j.exer.2018.11.011. Epub 2018 Nov 13.

PMID:
30445046
15.

Inter-observer variation in the histopathology reports of head and neck melanoma; a comparison between the seventh and eighth edition of the AJCC staging system.

Berger DMS, Wassenberg RM, Jóźwiak K, van de Wiel BA, Balm AJM, van den Berg JG, Klop WMC.

Eur J Surg Oncol. 2019 Feb;45(2):235-241. doi: 10.1016/j.ejso.2018.10.529. Epub 2018 Oct 25.

PMID:
30385156
16.

Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro.

Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, Jóźwiak K, Turski WA.

Naunyn Schmiedebergs Arch Pharmacol. 2019 Feb;392(2):209-217. doi: 10.1007/s00210-018-1572-7. Epub 2018 Oct 29.

PMID:
30370429
17.

Risk of diabetes after para-aortic radiation for testicular cancer.

Groot HJ, Gietema JA, Aleman BMP, Incrocci L, de Wit R, Witjes JA, Groenewegen G, de Brouwer P, Meijer OWM, Hulshof MCCM, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, van den Bergh ACM, Kerst JM, van den Belt-Dusebout AW, Lubberts S, Jóźwiak K, Horenblas S, van Leeuwen FE, Schaapveld M.

Br J Cancer. 2018 Oct;119(7):901-907. doi: 10.1038/s41416-018-0248-x. Epub 2018 Oct 9.

PMID:
30297773
18.

Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH2) with anti-inflammatory activity in the mouse models of colitis.

Salaga M, Binienda A, Draczkowski P, Kosson P, Kordek R, Jozwiak K, Fichna J.

Peptides. 2018 Oct;108:34-45. doi: 10.1016/j.peptides.2018.08.011. Epub 2018 Sep 1.

PMID:
30179653
19.

Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro.

Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, Jóźwiak K, Turski WA.

Neurotox Res. 2019 Jan;35(1):244-254. doi: 10.1007/s12640-018-9952-9. Epub 2018 Sep 3.

20.

Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.

Groot HJ, Lubberts S, de Wit R, Witjes JA, Kerst JM, de Jong IJ, Groenewegen G, van den Eertwegh AJM, Poortmans PM, Klümpen HJ, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, Incrocci L, van den Bergh ACM, Jóźwiak K, van den Belt-Dusebout AW, Horenblas S, Gietema JA, van Leeuwen FE, Schaapveld M.

J Clin Oncol. 2018 Aug 20;36(24):2504-2513. doi: 10.1200/JCO.2017.77.4174. Epub 2018 Jul 10.

PMID:
29989856
21.

Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease.

Chioua M, Buzzi E, Moraleda I, Iriepa I, Maj M, Wnorowski A, Giovannini C, Tramarin A, Portali F, Ismaili L, López-Alvarado P, Bolognesi ML, Jóźwiak K, Menéndez JC, Marco-Contelles J, Bartolini M.

Eur J Med Chem. 2018 Jul 15;155:839-846. doi: 10.1016/j.ejmech.2018.06.044. Epub 2018 Jun 19.

PMID:
29958119
22.

The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma.

Ottenhof SR, Djajadiningrat RS, Thygesen HH, Jakobs PJ, Jóźwiak K, Heeren AM, de Jong J, Sanders J, Horenblas S, Jordanova ES.

Front Immunol. 2018 Jun 11;9:1253. doi: 10.3389/fimmu.2018.01253. eCollection 2018.

23.

Tumor Resection Margin Definitions in Breast-Conserving Surgery: Systematic Review and Meta-analysis of the Current Literature.

Brouwer de Koning SG, Vrancken Peeters MTFD, Jóźwiak K, Bhairosing PA, Ruers TJM.

Clin Breast Cancer. 2018 Aug;18(4):e595-e600. doi: 10.1016/j.clbc.2018.04.004. Epub 2018 Apr 13. Review.

PMID:
29731404
24.

Breast-specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: Results from the randomized COBALT study.

Volders JH, Negenborn VL, Haloua MH, Krekel NMA, Jóźwiak K, Meijer S, van den Tol PM.

J Surg Oncol. 2018 Apr;117(5):1001-1008. doi: 10.1002/jso.25012. Epub 2018 Feb 23.

PMID:
29473960
25.

High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors.

de Vries S, Schaapveld M, van Nimwegen FA, Jóźwiak K, Lugtenburg PJ, Daniëls LA, Roesink JM, van der Maazen RWM, Kok WEM, Aleman BMP, van Leeuwen FE.

Br J Cancer. 2018 Mar 20;118(6):887-895. doi: 10.1038/bjc.2017.476. Epub 2018 Jan 30.

26.

Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.

Targowska-Duda KM, Kaczor AA, Jozwiak K, Arias HR.

J Biomol Struct Dyn. 2019 Feb;37(2):411-439. doi: 10.1080/07391102.2018.1427634. Epub 2018 Feb 16.

PMID:
29363414
27.

Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: A population-based cohort study.

Dackus GMHE, Jóźwiak K, Sonke GS, van der Wall E, van Diest PJ, Hauptmann M, Siesling S, Linn SC.

Eur J Cancer. 2018 Feb;90:92-101. doi: 10.1016/j.ejca.2017.11.010. Epub 2017 Dec 21.

28.

Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity.

Elbers JBW, Al-Mamgani A, Paping D, van den Brekel MWM, Jóźwiak K, de Boer JP, Karakullukcu B, Verheij M, Zuur CL.

Oral Oncol. 2017 Dec;75:163-168. doi: 10.1016/j.oraloncology.2017.11.006.

PMID:
29224815
29.

Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study.

Dackus GM, Ter Hoeve ND, Opdam M, Vreuls W, Varga Z, Koop E, Willems SM, Van Deurzen CH, Groen EJ, Cordoba A, Bart J, Mooyaart AL, van den Tweel JG, Zolota V, Wesseling J, Sapino A, Chmielik E, Ryska A, Amant F, Broeks A, Kerkhoven R, Stathonikos N, Veta M, Voogd A, Jozwiak K, Hauptmann M, Hoogstraat M, Schmidt MK, Sonke G, van der Wall E, Siesling S, van Diest PJ, Linn SC.

BMJ Open. 2017 Nov 14;7(11):e017842. doi: 10.1136/bmjopen-2017-017842.

30.

Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria.

Madu MF, Franke V, Bruin MM, Berger DMS, Bierman C, Jóźwiak K, Klop WMC, Wouters MWJM, van Akkooi ACJ, Van de Wiel BA.

Eur J Cancer. 2017 Dec;87:212-215. doi: 10.1016/j.ejca.2017.09.002. Epub 2017 Oct 3. No abstract available.

PMID:
28986137
31.

Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione - a novel anticonvulsant drug candidate.

Kaproń B, Łuszczki J, Paneth A, Wujec M, Siwek A, Karcz T, Mordyl B, Głuch-Lutwin M, Gryboś A, Nowak G, Pająk K, Jóźwiak K, Tomczykowski A, Plech T.

Int J Med Sci. 2017 Jul 18;14(8):741-749. doi: 10.7150/ijms.20001. eCollection 2017.

32.

New approach in evaluation of ceramic-polymer composite bioactivity and biocompatibility.

Borkowski L, Sroka-Bartnicka A, Polkowska I, Pawlowska M, Palka K, Zieba E, Slosarczyk A, Jozwiak K, Ginalska G.

Anal Bioanal Chem. 2017 Sep;409(24):5747-5755. doi: 10.1007/s00216-017-0518-0. Epub 2017 Jul 26.

33.

GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts.

Bernier M, Catazaro J, Singh NS, Wnorowski A, Boguszewska-Czubara A, Jozwiak K, Powers R, Wainer IW.

Int J Cancer. 2017 Nov 15;141(10):2131-2142. doi: 10.1002/ijc.30904. Epub 2017 Aug 7.

34.

Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain-Its Possible Clinical Applications.

Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, Jóźwiak K, Turski WA.

Neurotox Res. 2017 Nov;32(4):639-648. doi: 10.1007/s12640-017-9781-2. Epub 2017 Jul 21.

35.

The presence of kynurenine aminotransferases in the human cornea: Evidence from bioinformatics analysis of gene expression and immunohistochemical staining.

Matysik-Woźniak A, Jünemann A, Turski WA, Wnorowski A, Jóźwiak K, Paduch R, Okuno E, Moneta-Wielgoś J, Chorągiewicz T, Maciejewski R, Rejdak R.

Mol Vis. 2017 Jun 26;23:364-371. eCollection 2017.

36.

Concurrent activation of β2-adrenergic receptor and blockage of GPR55 disrupts pro-oncogenic signaling in glioma cells.

Wnorowski A, Such J, Paul RK, Wersto RP, Indig FE, Jozwiak K, Bernier M, Wainer IW.

Cell Signal. 2017 Aug;36:176-188. doi: 10.1016/j.cellsig.2017.05.006. Epub 2017 May 8.

37.

Kynurenic Acid and Neuroprotective Activity of the Ketogenic Diet in the Eye.

Zarnowski T, Tulidowicz-Bielak M, Zarnowska I, Mitosek-Szewczyk K, Wnorowski A, Jozwiak K, Gasior M, Turski WA.

Curr Med Chem. 2017;24(32):3547-3558. doi: 10.2174/0929867324666170509120257. Review.

PMID:
28486923
38.

Clinical prognostic markers in stage IIIC melanoma.

Madu MF, Schopman JHH, Berger DMS, Klop WMC, Jóźwiak K, Wouters MWJM, van der Hage JA, van Akkooi ACJ.

J Surg Oncol. 2017 Aug;116(2):244-251. doi: 10.1002/jso.24635. Epub 2017 Apr 15.

PMID:
28411392
39.

One-stop-shop with confocal microscopy imaging vs. standard care for surgical treatment of basal cell carcinoma: an open-label, noninferiority, randomized controlled multicentre trial.

Kadouch DJ, Elshot YS, Zupan-Kajcovski B, van Haersma de With ASE, van der Wal AC, Leeflang M, Jóźwiak K, Wolkerstorfer A, Bekkenk MW, Spuls PI, de Rie MA.

Br J Dermatol. 2017 Sep;177(3):735-741. doi: 10.1111/bjd.15559. Epub 2017 Aug 3.

PMID:
28391599
40.

Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

van Eden WJ, Kok NF, Jóźwiak K, Lahaye ML, Beets GL, van Leerdam ME, Boot H, Aalbers AG.

Dis Colon Rectum. 2017 May;60(5):477-487. doi: 10.1097/DCR.0000000000000774.

PMID:
28383447
41.

Cosmetic outcome and quality of life are inextricably linked in breast-conserving therapy.

Volders JH, Negenborn VL, Haloua MH, Krekel NMA, Jóźwiak K, Meijer S, M van den Tol P.

J Surg Oncol. 2017 Jun;115(8):941-948. doi: 10.1002/jso.24615. Epub 2017 Mar 23.

PMID:
28334419
42.

Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.

Madu MF, Deken MM, van der Hage JA, Jóźwiak K, Wouters MWJM, van Akkooi ACJ.

Ann Surg Oncol. 2017 Jul;24(7):1997-2005. doi: 10.1245/s10434-017-5803-9. Epub 2017 Feb 10.

PMID:
28188500
43.

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design.

Rigter LS, Spaander MC, Moons LM, Bisseling TM, Aleman BM, de Boer JP, Lugtenburg PJ, Janus CP, Petersen EJ, Roesink JM, Raemaekers JM, van der Maazen RW, Cats A, Bleiker EM, Snaebjornsson P, Carvalho B, Lansdorp-Vogelaar I, Jóźwiak K, Te Riele H, Meijer GA, van Leeuwen FE, van Leerdam ME.

BMC Cancer. 2017 Feb 7;17(1):112. doi: 10.1186/s12885-017-3089-8.

44.

Using DRS during breast conserving surgery: identifying robust optical parameters and influence of inter-patient variation.

de Boer LL, Hendriks BH, van Duijnhoven F, Peeters-Baas MT, Van de Vijver K, Loo CE, Jóźwiak K, Sterenborg HJ, Ruers TJ.

Biomed Opt Express. 2016 Nov 17;7(12):5188-5200. doi: 10.1364/BOE.7.005188. eCollection 2016 Dec 1.

45.

Intraoperative ultrasound guidance in breast-conserving surgery shows superiority in oncological outcome, long-term cosmetic and patient-reported outcomes: Final outcomes of a randomized controlled trial (COBALT).

Volders JH, Haloua MH, Krekel NM, Negenborn VL, Kolk RH, Lopes Cardozo AM, Bosch AM, de Widt-Levert LM, van der Veen H, Rijna H, Taets van Amerongen AH, Jóźwiak K, Meijer S, van den Tol MP.

Eur J Surg Oncol. 2017 Apr;43(4):649-657. doi: 10.1016/j.ejso.2016.11.004. Epub 2016 Nov 23.

PMID:
27916314
46.

Clinical Prognostic Markers in Stage IIIB Melanoma.

Madu MF, Wouters MW, Klop WM, van der Hiel B, van de Wiel BA, Jóźwiak K, van der Hage JA, van Akkooi AC.

Ann Surg Oncol. 2016 Dec;23(13):4195-4202. Epub 2016 Jul 5.

PMID:
27380642
47.

A vital region for human glycoprotein hormone trafficking revealed by an LHB mutation.

Potorac I, Rivero-Müller A, Trehan A, Kiełbus M, Jozwiak K, Pralong F, Hafidi A, Thiry A, Ménagé JJ, Huhtaniemi I, Beckers A, Daly AF.

J Endocrinol. 2016 Dec;231(3):197-207. Epub 2016 Sep 21.

48.

Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.

van den Belt-Dusebout AW, Spaan M, Lambalk CB, Kortman M, Laven JS, van Santbrink EJ, van der Westerlaken LA, Cohlen BJ, Braat DD, Smeenk JM, Land JA, Goddijn M, van Golde RJ, van Rumste MM, Schats R, Józwiak K, Hauptmann M, Rookus MA, Burger CW, van Leeuwen FE.

JAMA. 2016 Jul 19;316(3):300-12. doi: 10.1001/jama.2016.9389.

PMID:
27434442
49.

Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.

Ter Brugge P, Kristel P, van der Burg E, Boon U, de Maaker M, Lips E, Mulder L, de Ruiter J, Moutinho C, Gevensleben H, Marangoni E, Majewski I, Józwiak K, Kloosterman W, van Roosmalen M, Duran K, Hogervorst F, Turner N, Esteller M, Cuppen E, Wesseling J, Jonkers J.

J Natl Cancer Inst. 2016 Jul 5;108(11). doi: 10.1093/jnci/djw148. Print 2016 Nov.

PMID:
27381626
50.

Neoadjuvant chemotherapy in breast-conserving surgery - Consequences on margin status and excision volumes: A nationwide pathology study.

Volders JH, Haloua MH, Krekel NM, Negenborn VL, Barbé E, Sietses C, Jóźwiak K, Meijer S, van den Tol MP; “the nationwide network and registry of histo- and cytopathology in the Netherlands (PALGA)”.

Eur J Surg Oncol. 2016 Jul;42(7):986-93. doi: 10.1016/j.ejso.2016.02.252. Epub 2016 May 4.

PMID:
27211343

Supplemental Content

Loading ...
Support Center